A PHASE II, DOSE-RANGING STUDY WITH CD-NP, A CHIMERIC NATRIURETIC PEPTIDE, IN ACUTE DECOMPENSATED HEART FAILURE PATIENTS WITH RENAL COMPROMISE Academic Article uri icon

abstract

  • Background: CD-NP, a chimeric natriuretic peptide, with veno-arterial vasodilation may simultaneously unload the heart and kidney in acute decompensated failure (ADHF) patients. This dose-ranging study investigated the safety and tolerability of CD-NP in ADHF patients (pts).

publication date

  • January 1, 2011